Vaccine Adjuvants Market Set to Soar Past USD 2.90 Billion by 2030 [Yahoo! Finance]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Yahoo! Finance
The vaccine innovation and development, growing prevalence of infectious diseases, increasing global vaccination initiatives, demand for enhanced vaccine efficacy, advancements in immunology research, expanded use of recombinant vaccines, rising awareness of preventive healthcare, regulatory support for vaccine adjuvants, population growth, and the need for vaccine dose sparing is fueling the market's growth. Westford, USA, Jan. 25, 2024 (GLOBE NEWSWIRE) -- According to SkyQuest's latest global research of the Vaccine Adjuvants Market , adoption of synthetic adjuvants, personalized medicine in vaccine development, focus on mRNA and nucleic acid vaccines, advancements in nanotechnology for adjuvant delivery, combination adjuvant strategies, development of thermo-stable adjuvants for global distribution, research in immune modulation, utilization of plant-based adjuvants, expanding applications in oncology vaccines, and the exploration of digital technologies for adjuvant development
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024PR Newswire
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Global Human Vaccines Market (2023-2028) [Yahoo! Finance]Yahoo! Finance
- Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% [Yahoo! Finance]Yahoo! Finance
DVAX
Earnings
- 2/22/24 - Beat
DVAX
Sec Filings
- 4/26/24 - Form DEFA14A
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- DVAX's page on the SEC website